A print ad for Genentech’s Boniva overstated the osteoporosis drug’s efficacy, said the FDA’s DDMAC in an untitled letter. The agency took issue with the claim in the ad, which features Sally Field, ...
Osteoporosis drugs are big sellers, bringing in some $2 billion in 2008 alone. Now one of the newest of those drugs, ibandronate, also known as Boniva, has scored major (and no doubt expensive) ...
A federal judge issued a ruling Thursday allowing GlaxoSmithKline and Roche to continue marketing the osteoporosis drug Boniva, shooting down an injunction filed by market rivals to halt the drug’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results